Enhanced Games' $62M quarter puts a price on buying legitimacy

Enhanced Group, the telehealth company that staged the Enhanced Games in Las Vegas in May, reported a net loss of nearly $62 million for the second quarter, with much of it attributed to hosting the event [s1c1]. Against $17.7 million in revenue, most of which came from sponsorships tied to the games rather than the telehealth business the company was built on, that is a usable number for what it costs to buy sporting legitimacy [s1c3].

Work the arithmetic. Revenue of $17.7 million and a loss of nearly $62 million imply roughly $79.7 million of costs in the quarter [s1d1], or about $4.50 spent for every dollar collected [s1d2]. The company went public earlier this year at a $1.2 billion valuation, having been founded in 2023 [s1c6], which means a single quarter's loss consumed something on the order of 5 percent of the IPO valuation [s1d3].

The revenue mix is the part product people should sit with. Enhanced sells personalized health treatments through a digital telehealth platform, including FDA-approved peptides, testosterone injections and GLP-1s [s1c6]. But the money in Q2 came from sponsors buying proximity to a spectacle, and TechCrunch reports that scant information is available about how the core business is actually performing [s1c4]. That is a marketing line item reported as revenue, and it obscures the only question that matters: whether the telehealth funnel converts without an event attached.

The event itself did not deliver the demo. The games were billed by their creators as something that would fundamentally transform organized sports [s1c16], yet only one world record fell, and it came in swimming, where records break often [s1c5]. The competition was backed by investors including Peter Thiel and staffed by veterans of the crypto, AI and biotech industries, and was widely derided as the "steroid Olympics" [s1c7].

The pivot is already in the filing. The report casts doubt on earlier executive claims that the games would be annual, noting the company would either need far more revenue or tolerance for losing tens of millions a year [s1c8]. It also promotes Enhanced Breakers, a new online series the company says "operates at a fraction of the cost of a full Games event" while keeping "athletes competing, audiences engaged, sponsors interested, and performance medicine in front of the world year-round" [s1c9]. Translated: keep the marketing surface, drop the stadium.

Meanwhile the category is moving without them. TechCrunch reports the peptide business is booming, helped by a Trump administration FDA decision reclassifying substances long in a legal gray area, though an additional review is still required before sales open up [s1c10]. The FDA's parent agency, HHS, is overseen by Robert F. Kennedy Jr., whose health views have been characterized as dangerous by professionals inside and outside government [s1c11]. Silicon Valley startups such as Superpower and Noho Labs are growing faster than state regulators can write rules [s1c12].

Watch Q3, the first quarter with no games in it. That report is the first clean read on telehealth revenue, and on whether sponsors follow Enhanced onto the internet.